People · Operator

Mark A. Edwards

Named in public records as an officer, director or promoter · active 2009–2013 · Other Health Care

1
Companies
14
Filings
$11.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Dr. Tattoff, Inc.Other Health CareSeed$11.3M$12.0M2009
Operator network

Mark A. Edwards at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

EUGENE A. BAUER · 7 companies · 1 sharedEUGENE A. BAUERGene E. Burleson · 5 companies · 1 sharedGene E. BurlesonJOEL S. KANTER · 3 companies · 1 sharedJOEL S. KANTERJames Morel · 2 companies · 1 sharedJames MorelEugene T. Bauer · 1 companies · 1 sharedEugene T. BauerGene E. Burlson · 1 companies · 1 sharedGene E. BurlsonHARRY L. ZIMMERMAN · 1 companies · 1 sharedHARRY L. ZIMMERMANIan A. Kirby · 1 companies · 1 sharedIan A. KirbyIan T. Kirby · 1 companies · 1 sharedIan T. KirbyJoel P. Kanter · 1 companies · 1 sharedJoel P. KanterJoel T. Kanter · 1 companies · 1 sharedJoel T. KanterJohn J. Klobnak · 1 companies · 1 sharedJohn J. KlobnakJohn P. Keefe · 1 companies · 1 sharedJohn P. KeefeWILLIAM A. KIRBY · 1 companies · 1 sharedWILLIAM A. KIRBYWilliam T. Kirby · 1 companies · 1 sharedWilliam T. KirbyDr. Tattoff, Inc. · $11.3M raisedDr. Tattoff, Inc.Mark A. EdwardsME
Mark A. Edwards Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Mark A. Edwards on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
EUGENE A. BAUER17
Gene E. Burleson15
JOEL S. KANTER13
James Morel12
Joel T. Kanter11
WILLIAM A. KIRBY11
HARRY L. ZIMMERMAN11
Joel P. Kanter11
Ian A. Kirby11
John J. Klobnak11
Ian T. Kirby11
Gene E. Burlson11
John P. Keefe11
William T. Kirby11
Eugene T. Bauer11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.